These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7705973)

  • 1. Computational molecular modeling in peptide drug design.
    Nikiforovich GV
    Int J Pept Protein Res; 1994 Dec; 44(6):513-31. PubMed ID: 7705973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational design and optimization of novel d-peptide TNFα inhibitors.
    Yang W; Zhang Q; Zhang C; Guo A; Wang Y; You H; Zhang X; Lai L
    FEBS Lett; 2019 Jun; 593(12):1292-1302. PubMed ID: 31102258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational flexibility in designing peptides for immunology: the molecular dynamics approach.
    Stavrakoudis A
    Curr Comput Aided Drug Des; 2010 Sep; 6(3):207-22. PubMed ID: 20412039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of nonpeptides from peptide ligands for peptide receptors.
    Hruby VJ; Qui W; Okayama T; Soloshonok VA
    Methods Enzymol; 2002; 343():91-123. PubMed ID: 11665597
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural features of the bradykinin receptor as determined by computer simulations, mutagenesis experiments, and conformationally constrained ligands: establishing the framework for the design of new antagonists.
    Kyle DJ
    Braz J Med Biol Res; 1994 Aug; 27(8):1757-79. PubMed ID: 7749367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design of antagonist peptide of hIL-6 based on the binding epitope of hIL-6 by computer-aided molecular modeling.
    Feng J; Li Y; Shen B
    Peptides; 2004 Jul; 25(7):1123-31. PubMed ID: 15245871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles.
    Raman S; Machaidze G; Lustig A; Aebi U; Burkhard P
    Nanomedicine; 2006 Jun; 2(2):95-102. PubMed ID: 17292121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design and characterization of a Novel IL-6 antagonist peptide.
    Yang Z; Feng J; Li Y; Hu M; Song L; Yu M; Qin W; Shen B
    Mol Immunol; 2005 May; 42(9):1015-21. PubMed ID: 15829291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational design of selective peptides to discriminate between similar PDZ domains in an oncogenic pathway.
    Zheng F; Jewell H; Fitzpatrick J; Zhang J; Mierke DF; Grigoryan G
    J Mol Biol; 2015 Jan; 427(2):491-510. PubMed ID: 25451599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of peptides.
    Kuczera K
    Methods Mol Biol; 2015; 1268():15-41. PubMed ID: 25555719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo designed transmembrane peptides activating the α5β1 integrin.
    Mravic M; Hu H; Lu Z; Bennett JS; Sanders CR; Orr AW; DeGrado WF
    Protein Eng Des Sel; 2018 May; 31(5):181-190. PubMed ID: 29992271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-peptide docking: opportunities and challenges.
    Ciemny M; Kurcinski M; Kamel K; Kolinski A; Alam N; Schueler-Furman O; Kmiecik S
    Drug Discov Today; 2018 Aug; 23(8):1530-1537. PubMed ID: 29733895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of emulsification peptides.
    Sheehan D; Carey K; O'Sullivan S
    Adv Food Nutr Res; 1998; 42():93-129. PubMed ID: 9597726
    [No Abstract]   [Full Text] [Related]  

  • 14. Patenting computer-designed peptides.
    Patel S; Stott IP; Bhakoo M; Elliott P
    J Comput Aided Mol Des; 1998 Nov; 12(6):543-56. PubMed ID: 9879502
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kleynhans J; Kruger HG; Cloete T; Zeevaart JR; Ebenhan T
    Curr Med Chem; 2020; 27(41):7048-7063. PubMed ID: 32364063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational, computer-enabled peptide drug design: principles, methods, applications and future directions.
    Diller DJ; Swanson J; Bayden AS; Jarosinski M; Audie J
    Future Med Chem; 2015; 7(16):2173-93. PubMed ID: 26510691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational identification of inhibitors of protein-protein interactions.
    Zhong S; Macias AT; MacKerell AD
    Curr Top Med Chem; 2007; 7(1):63-82. PubMed ID: 17266596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational and topographical considerations in the design of biologically active peptides.
    Hruby VJ
    Biopolymers; 1993 Jul; 33(7):1073-82. PubMed ID: 8102072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic alpha-helical peptides incorporating intercalators for DNA recognition.
    Brown CL; Harding MM
    J Mol Recognit; 1994 Sep; 7(3):215-20. PubMed ID: 7880546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling in the design of peptidomimetics and peptide surrogates.
    Perez JJ; Corcho F; Llorens O
    Curr Med Chem; 2002 Dec; 9(24):2209-29. PubMed ID: 12470243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.